ResearchCon 2024 | Opening Keynote: Where We Are: CF Drug Pipeline Developments
215 بار بازدید -
2 ماه پیش
-
During the opening keynote of
During the opening keynote of ResearchCon 2024, speakers Art Brace, PhD, JP Clancy, MD, and Nicole Kohr speak about the dynamic landscape of cystic fibrosis research and development. Explore the breadth of therapies currently in development for CF, including genetic therapies, anti-infectives, CFTR modulators, and beyond.
Originally recorded April 30, 2024.
00:00 | Where We Are: drug pipeline developments
07:23 | The complexities of new drug development
13:00 | How does CF affect the body?
16:00 | Why cystic fibrosis transmembrane conductance regulator (CFTR) therapies make sense
18:00 | Learn about the new CFTR modulators
23:10 | Genetic-based therapies for modulator-ineligible/intolerant
29:50 | What are the genetic-based therapies currently in clinical trials?
33:24 | Understanding genetic therapeutic development for people with CF without modulators
38:40 | Where are we with infection research?
42:54 | Focusing on an anti-infective portfolio
46:02 | Where are we going in drug development for 2024?
46:43 | How to make the best out of ResearchCon
Originally recorded April 30, 2024.
00:00 | Where We Are: drug pipeline developments
07:23 | The complexities of new drug development
13:00 | How does CF affect the body?
16:00 | Why cystic fibrosis transmembrane conductance regulator (CFTR) therapies make sense
18:00 | Learn about the new CFTR modulators
23:10 | Genetic-based therapies for modulator-ineligible/intolerant
29:50 | What are the genetic-based therapies currently in clinical trials?
33:24 | Understanding genetic therapeutic development for people with CF without modulators
38:40 | Where are we with infection research?
42:54 | Focusing on an anti-infective portfolio
46:02 | Where are we going in drug development for 2024?
46:43 | How to make the best out of ResearchCon
2 ماه پیش
در تاریخ 1403/02/31 منتشر شده
است.
215
بـار بازدید شده